
CARI Therapeutics has received additional funding from the National Institute of Drug Abuse to refine their tiny implantable biosensor that could help combat the deadly and destructive opioid crisis in the United States.
CARI Therapeutics has received additional funding from the National Institute of Drug Abuse to refine their tiny implantable biosensor that could help combat the deadly and destructive opioid crisis in the United States.
Copyright © 2022 Biotech Networks, LLC